Since its inception in 2016, the fund has achieved the following 
  • Over 48% of eligible Quad faculty applied
  • Reviewed 186 grant proposals
  • Q-FASTR awardees had 5 new start-up companies and over $180 million in follow-on funding, which corresponds to over 15 times our investment

2024 Awardees

Congratulations to the following award recipients of the 2024 Q-FASTR RFP:

  • Karen Adelman and Zuzana Tothova (Dana-Farber Cancer Institute)
  • Stephen Blacklow
  • George Church
  • Sloan Devlin
  • Lucas Farnung
  • Wade Harper
  • Timothy Mitchison
  • Peter Park and Doga Gulhan (Massachusetts General Hospital)
  • Norbert Perrimon
  • David Scadden
  • Pamela Silver
  • Amy Wagers

For more details about their research, please visit the Projects section.

Q-FASTR Projects
2023 Q-FASTR Poster Showcase & Reception

Q-FASTR is dedicated to transforming cutting-edge basic research at HMS into tomorrow’s therapeutics, diagnostics, and related technologies. By championing early ideas and enveloping them with financial and scientific support, we cultivate breakthroughs that have the potential to reshape medicine.

Ifat Rubin-Bejerano
Senior Director, Translational Research Programs, Harvard Medical School